#CORONAVIRUS
AstraZeneca Withdraws Swiss Application for Coronavirus Vaccine
AstraZeneca withdraws Swiss application for coronavirus vaccine
Vaccine
British pharmaceutical company AstraZeneca has withdrawn its application for approval of its coronavirus vaccine in Switzerland.
The company said on Thursday that it withdrew it’s application after after Swiss authorities indicated that it would only be cleared for use in people aged 50 and older.
AstraZeneca filed its application to Swissmedic in October 2020.
There has been regular contact between the company and the regulators since.
Swissmedic had repeatedly said that it was lacking sufficient data to approve the drug for broad use.
The country originally ordered 5.3 million doses of AstraZeneca vaccine, but has passed on 440,000 of those to a group of five developing countries while the wait for approval dragged on.
Delta Refutes Aproko Doctor’s Claim of Prioritising Flyover Over Primary Healthcare
Delta Opens Registration for Tertiary Institutions Entrepreneurship Programme
Bayo Ojulari Reveals Political Pressure to Keep Nigeria’s Refineries Operating Despite Heavy Losses
Isoko South Chair Felicitates Delta First Lady Tobore on Her 56th Birthday
Isoko North Boss Celebrates Delta First Lady, ‘True and Worthy Daughter of Isoko Nation,’ on Her 56th Birthday
Former MD of NEXIM Bank, Robert Orya, Jailed 490 Years Over Alleged N2.4 Billion Fraud
Delta Police Rescue Four Abducted Passengers, Arrest Suspected Cultist
Sen. Nwoko Eulogies Delta First Lady, Tobore Oborevwori at 56
Oborevwori Celebrates Wife, Tobore at 56
Aniagwu Condoles DBS, Delta Journalists Over Death of Vivian Nkechika
Cubana Millennium City Asaba: Proof of Oborevwori’s Investor-Friendly Delta
80bn Fraud Trial of Kogi Ex-Governor’s Yahaya Bello Continues as Court Seeks Proof of Payment for Evidence
Okesanjo: Meet Newly Appointed ICPC’s Resident Consultant, Strategy and Communications
Nigeria-France Strengthen Defence Cooperation as COAS Receives French Defence Attache
